3-iodobenzylguanidine has been researched along with Multiple System Atrophy Syndrome in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (10.53) | 18.2507 |
2000's | 17 (44.74) | 29.6817 |
2010's | 11 (28.95) | 24.3611 |
2020's | 6 (15.79) | 2.80 |
Authors | Studies |
---|---|
Bösch, S; Djamshidian, A; Donnemiller, E; Eckhardt, C; Eschlböck, S; Fanciulli, A; Kiechl, S; Krismer, F; Mair, K; Metzler, B; Poewe, W; Raccagni, C; Scherfler, C; Seppi, K; Uprimny, C; Virgolini, I; Wenning, GK | 1 |
An, YS; Chang, J; Kim, JY; Kim, MH; Kim, MS; Park, DG; Yoon, JH | 1 |
Hayashi, H; Iseki, C; Ishizawa, K; Kawakatsu, S; Kobayashi, R; Morioka, D; Otani, K | 1 |
Garg, D | 1 |
Calandra-Buonaura, G; Cason, E; Cortelli, P; Devigili, G; Donadio, V; Eleopra, R; Giannini, G; Giannoccaro, MP; Incensi, A; Liguori, R; Rizzo, G | 1 |
Brumberg, J; Buck, A; Doppler, K; Isaias, IU; Kuzkina, A; Lapa, C; Mammadova, S; Sommer, C; Volkmann, J | 1 |
Dillmann, U; Ezziddin, S; Fassbender, K; Leppert, D; Schaefer-Schuler, A; Soboll, L; Spiegel, J | 1 |
Alves Do Rego, C; Anheim, M; Lagha-Boukbiza, O; Lefebvre, F; Marcel, C; Namer, IJ; Renaud, M; Tranchant, C | 1 |
Hoshino, T; Irie, KI; Kamada, T; Kida, H; Miura, S; Taniwaki, T; Yamanishi, Y | 1 |
Hayashi, R; Kohsaka, M; Oeda, T; Sawada, H; Tomita, S; Umemura, A; Yamamoto, K | 1 |
Hirata, K; Iwanami, M; Miyamoto, M; Miyamoto, T; Nishibayashi, M; Suzuki, K | 1 |
Chung, EJ; Kim, BJ; Lee, GH; Lee, WY; Yoon, WT | 1 |
Hama, T; Hirayama, M; Hori, N; Nakamura, T; Sobue, G; Takamori, M; Uchida, K; Yamashita, F | 1 |
Abbruzzese, G; Bandettini di Poggio, M; Marchese, R; Marini, C; Morbelli, SD; Nobili, F; Pomposelli, E; Sambuceti, G; Villa, G | 1 |
Hamamoto, M; Katayama, Y; Nagayama, H; Nishiyama, Y; Ueda, M; Yamazaki, M | 1 |
Baba, T; Hasegawa, T; Kikuchi, A; Konno, M; Sugeno, N; Takeda, A | 1 |
Berganzo, K; Gómez-Esteban, JC; Iodice, V; Lezcano, E; Llorens, V; Low, D; Mathias, CJ; Sánchez-Manso, JC; Somme, JH; Tijero, B; Vichayanrat, E; Zarranz, JJ | 1 |
Cason, E; Cocciolillo, F; Di Giuda, D; Giordano, A; Stefanelli, A; Treglia, G | 1 |
Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kametaka, S; Kurata, T; Manabe, Y; Morimoto, N; Ohta, T; Ohta, Y; Sato, S; Takao, Y | 1 |
Hirano, T; Ichikawa, Y; Kuzuhara, S; Matsumura, K; Murashima, S; Sakuma, H; Takeda, K | 1 |
Fujino, S; Higashi, K; Hirose, G; Hori, A; Kaito, M; Kakeshita, K; Kataoka, S; Miaki, M; Saiki, M; Saiki, S; Sakai, K; Taki, S | 1 |
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F | 1 |
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Tamura, A; Udaka, F | 1 |
Inoue, K; Mochio, S; Morita, M; Oka, H; Onouchi, K; Yoshioka, M | 1 |
Kim, HJ; Lee, PH; Yeo, SH; Youm, HY | 1 |
Kim, JS; Lee, KS; Song, IU | 1 |
Boesch, S; Donnemilier, E; Heute, D; Köllensperger, M; Liener, C; Mair, KJ; Mueller, J; Poewe, W; Sawires, M; Scherfler, C; Schocke, MF; Seppi, K; Virgolini, I; Wenning, GK | 1 |
Hamamoto, M; Katayama, Y; Mori, O; Nagayama, H; Nishiyama, Y; Ueda, M; Yamazaki, M | 1 |
Hayashi, M; Hirai, S; Yoshita, M | 1 |
Yoshita, M | 2 |
Orimo, S; Ozawa, E; Tanaka, H; Tsuchiya, K; Yasui, H | 1 |
Braune, S; Lücking, CH; Reinhardt, M; Riedel, A; Schnitzer, R | 1 |
Braune, S; Jüngling, FD; Krause, TM; Reinhardt, MJ | 1 |
Fujiwara, H; Matsuo, H; Murase, M; Nagashima, K; Nishida, H; Satomi, K; Takatsu, H; Watanabe, S | 1 |
Nakade, S; Oka, T; Orimo, S; Ozawa, E; Takahashi, H; Tsuchiya, K; Wakabayashi, K; Yoshimoto, M | 1 |
Goldstein, DS | 1 |
Braune, S | 1 |
3 review(s) available for 3-iodobenzylguanidine and Multiple System Atrophy Syndrome
Article | Year |
---|---|
Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.
Topics: 3-Iodobenzylguanidine; Confidence Intervals; Data Interpretation, Statistical; Diagnosis, Differential; Humans; Image Processing, Computer-Assisted; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Tomography, Emission-Computed, Single-Photon | 2011 |
Cardiac sympathetic neuroimaging to distinguish multiple system atrophy from Parkinson disease.
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Dopamine; Fluorine Radioisotopes; Heart Conduction System; Humans; Multiple System Atrophy; Parkinson Disease; Radiopharmaceuticals; Sympathetic Nervous System | 2001 |
The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.
Topics: 3-Iodobenzylguanidine; Animals; Diagnosis, Differential; Humans; Multiple System Atrophy; Myocardium; Neurodegenerative Diseases; Parkinsonian Disorders; Radiopharmaceuticals | 2001 |
5 trial(s) available for 3-iodobenzylguanidine and Multiple System Atrophy Syndrome
Article | Year |
---|---|
MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Adenosine; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Galvanic Skin Response; Heart; Heart Rate; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Respiration; Sensitivity and Specificity; Sympathetic Fibers, Postganglionic; Tomography, Emission-Computed, Single-Photon; Valsalva Maneuver | 2009 |
Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Whole Body Imaging | 2010 |
Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Male; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Gland | 2005 |
[Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Sympathetic Nervous System | 1997 |
Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Heart; Humans; Iodine Radioisotopes; Lung; Male; Mediastinal Diseases; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals | 2000 |
30 other study(ies) available for 3-iodobenzylguanidine and Multiple System Atrophy Syndrome
Article | Year |
---|---|
Cardiac sympathetic innervation in Parkinson's disease versus multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Humans; Iodine; Multiple System Atrophy; Parkinson Disease; Prospective Studies | 2022 |
Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Humans; Intermediate Filaments; Lewy Body Disease; Multiple System Atrophy; Parkinson Disease; REM Sleep Behavior Disorder | 2023 |
Phenoconversion from rapid eye movement sleep behaviour disorder to multiple system atrophy is predicted by abnormal dopamine transporter imaging combined with normal
Topics: 3-Iodobenzylguanidine; Dopamine Plasma Membrane Transport Proteins; Humans; Multiple System Atrophy; Myocardial Perfusion Imaging; REM Sleep Behavior Disorder | 2020 |
The role of cardiac
Topics: 3-Iodobenzylguanidine; Dopamine Plasma Membrane Transport Proteins; Humans; Multiple System Atrophy; Myocardial Perfusion Imaging; Radionuclide Imaging; REM Sleep Behavior Disorder | 2020 |
Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Topics: 3-Iodobenzylguanidine; Aged; alpha-Synuclein; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Peripheral Nerves; Phosphorylation; Pure Autonomic Failure; Radionuclide Imaging; Radiopharmaceuticals; Skin | 2020 |
Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; alpha-Synuclein; Autonomic Fibers, Postganglionic; Female; Heart; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Fibers; Neural Conduction; Parkinson Disease; Peripheral Nervous System; Phosphorylation; Radionuclide Imaging; Radiopharmaceuticals; Skin | 2021 |
MIBG scintigraphy of the major salivary glands in multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Humans; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Salivary Glands; Sympathetic Nervous System | 2018 |
Prospective study of relevance of
Topics: 3-Iodobenzylguanidine; Biomarkers; Clonidine; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
MIBG myocardial scintigraphy in progressive supranuclear palsy.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrophy; Brain Stem; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive | 2019 |
Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Diffusion; Female; Humans; Male; Multiple System Atrophy; Parkinson Disease; Putamen; Radionuclide Imaging | 2013 |
123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Supranuclear Palsy, Progressive | 2008 |
Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System; Autonomic Nervous System Diseases; Blood Pressure; Disease Progression; Female; Heart Function Tests; Humans; Male; Middle Aged; Miotics; Multiple System Atrophy; Parkinson Disease; Pilocarpine; Pupil; Radionuclide Imaging; Radiopharmaceuticals; Reflex, Pupillary; ROC Curve | 2010 |
Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Humans; Iodine Radioisotopes; Longitudinal Studies; Male; Middle Aged; Multiple System Atrophy; Myocardial Perfusion Imaging; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Time Factors | 2010 |
Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Male; Mediastinum; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Severity of Illness Index; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2012 |
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2011 |
Increased myocardial uptake of iodine-123 metaiodobenzylguanidine on delayed images, compared with early images, in patients with multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Radionuclide Imaging; Radiopharmaceuticals; Time Factors | 2003 |
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Enzyme Inhibitors; Female; Gait Ataxia; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurologic Examination; Parkinson Disease; Phenotype; Radionuclide Imaging; Regression Analysis; Severity of Illness Index; Statistics, Nonparametric; Tremor | 2004 |
Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Aged; Female; Humans; Liver; Lung; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Thyroid Gland | 2005 |
Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System; Baroreflex; Cardiovascular System; Case-Control Studies; Humans; Iodine Radioisotopes; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Valsalva Maneuver | 2006 |
Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Humans; Male; Middle Aged; Multiple System Atrophy; Odorants; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Smell; Statistics as Topic | 2006 |
Dopa-responsive camptocormia in a patient with multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Antiparkinson Agents; Female; Heart; Humans; Levodopa; Middle Aged; Movement; Movement Disorders; Multiple System Atrophy; Parkinson Disease; Posture; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Area Under Curve; Case-Control Studies; Diffusion Magnetic Resonance Imaging; Heart; Humans; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tilt-Table Test; Time Factors | 2007 |
Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Fatal Outcome; Humans; Levodopa; Lewy Body Disease; Male; Multiple System Atrophy; Myocardium; Radiopharmaceuticals | 2008 |
Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Supranuclear Palsy, Progressive | 1998 |
[An autopsy case of multiple system atrophy presenting with rapid progression of autonomic disturbance].
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Brain; Disease Progression; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Olivopontocerebellar Atrophies; Radionuclide Imaging; Radiopharmaceuticals | 1999 |
Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals | 1999 |
Cardiac uptake of [123I]MIBG separates PD from multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Humans; Multiple System Atrophy; Myocardium; Parkinson Disease; Predictive Value of Tests; Radionuclide Imaging | 2000 |
Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Humans; Male; Multiple System Atrophy; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals | 2000 |
Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Tyrosine 3-Monooxygenase | 2001 |